[1] C J LI A B P L Averboukh. beta-Lapachone, a novel DNA topoisomerase I inhibitor with a mode of action different from camptothecin.[J]. The Journal of Biological Chemistry, 1993, 268 30: 22463-22468.
[2] S M WUERZBERGER. Induction of apoptosis in MCF-7:WS8 breast cancer cells by beta-lapachone.[J]. Cancer research, 1998, 58 9: 1876-1885.
[3] J J PINK. NAD(P)H:Quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity.[J]. The Journal of Biological Chemistry, 2000, 275 8: 5416-5424. DOI:
10.1074/jbc.275.8.5416[4] DAVID SIEGEL David R Chao Yan. NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones[J]. Biochemical pharmacology, 2012, 83 8: Pages 1033-1040. DOI:
10.1016/j.bcp.2011.12.017[5] Beta-lapachone suppresses radiation-induced activation of nuclear factor-kappaB